Clinical Trials Browser

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Brain Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis, Sarcoma, Ewing

Breast Neoplasms, Triple Negative Breast Neoplasms

Anatomic Stage IV Breast Cancer AJCC v8

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Recurrence, Endometrial Neoplasms

Adenocarcinoma of Endometrium

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Endometrial Neoplasms

Malignant Neoplasms of Female Genital Organs

Breast Neoplasms, Neoplasm, Residual

Breast Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Endometrial Neoplasms

Breast Neoplasms

ER-Positive Breast Cancer

Neoplasm Metastasis

Clinical Trials

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

FAIM

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

EVOLVE-BDT

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

TAPUR

ABBICAR

CAMPFIRE

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

I-SPY

Abemaciclib in Newly Diagnosed Meningioma Patients

CARABELA

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

BOUQUET

Abemaciclib and Letrozole to Treat Endometrial Cancer

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

MiRaDoR

VIOLET

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Abemaciclib With or Without Atezolizumab for mCRPC

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

ALPINE: Maintenance Letrozole/Abemaciclib

Next MONARCH 1

Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

GERTRUDE